Lycia Therapeutics Inc

Lycia Therapeutics, Inc. operates as a biotechnology company. The Company provides proprietary lysosomal targeting chimeras platform to discover and develop therapeutics that degrade extracellular and membrane bound proteins that drive a wide range of difficult-to-treat diseases, including autoimmune and inflammatory diseases. Lycia Therapeutics serves patients in the United States.